Dr. Madeleine V. Pahl, MD

Dr. Pahl practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Pahl's NPI, 1992885131, was assigned on October 16, 2006. Dr. Pahl graduated from UC Irvine School of Medicine in 1978. Dr. Pahl holds California license 000000G40573.

Dr. Pahl's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Pahl's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Pahl to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pahl practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Pahl's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Pahl is board certified in internal medicine by the American Board of Internal Medicine. Dr. Pahl is licensed in California.

Dmand AI lists chronic hypertension and chronic kidney disease among the conditions Dr. Pahl treats.

CMS data shows 160 Medicare services from Dr. Pahl across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $10,539 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Pahl in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pahl's median patient age at 65, with 55% women.

In 2024, Dr. Pahl wrote 43 Medicare Part D claims for 19 patients. 91% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pahl for performance year 2024, reported through an alternative payment model (APM). Dr. Pahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pahl as offering telehealth.

Dmand AI links 58 papers to Dr. Pahl, published from 2008 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Creatinine. Dr. Pahl has published most often in J Natl Med Assoc. Dr. Pahl's most frequent co-authors are Nosratola D. Vaziri, MD, Cyril H. Barton, MD and Sharon G. Adler, MD.

Dmand AI links Dr. Pahl to 1 clinical trial. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency.

CMS Open Payments shows 5 general payments to Dr. Pahl from 4 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 82% of the total. Diality Inc. paid the most, $813.

Dmand AI lists 6 awards for Dr. Pahl, most recently Top Doctors:LA Area in 2013.

Dr. Pahl graduated from UC Irvine School of Medicine in 1978. Dr. Pahl is a member of ASN.

Dr. Pahl is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.